Evidence map›Paper›PMID 31427688›Full record

Trial reportScientific reports2019

Effects of remote ischemic conditioning on kidney injury in at-risk patients undergoing elective coronary angiography (PREPARE study): a multicenter, randomized clinical trial.

François Roubille, Jean-Christophe Macia, Fabrice Ivanes, Denis Angoulvant, Victor Mateus, Loïc Belle, Meyer Elbaz, Olivier Morel, Alain Furber, Loïc Bière and 1 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

François RoubillePhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, CHU de Montpellier, Montpellier, France.
Jean-Christophe MaciaPhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, CHU de Montpellier, Montpellier, France.
Fabrice IvanesUniversité de Tours, EA 4245 Transplantation Immunité Inflammation & Loire Valley Cardiovascular Collaboration, CHRU de Tours, Service de Cardiologie, Tours, France.ORCID http://orcid.org/0000-0003-2407-6387
Denis AngoulvantUniversité de Tours, EA 4245 Transplantation Immunité Inflammation & Loire Valley Cardiovascular Collaboration, CHRU de Tours, Service de Cardiologie, Tours, France.ORCID http://orcid.org/0000-0003-0788-8092
Victor MateusCentre hospitalier de Laval, Service de Cardiologie, Laval, France.
Loïc BelleCentre hospitalier d'Annecy, Service de Cardiologie, Annecy, France.
Meyer ElbazUniversité Toulouse, CHU Toulouse, Service de Cardiologie, Toulouse, France.
Olivier MorelUniversité de Strasbourg, Service de Cardiologie, Strasbourg, France.
Alain FurberInstitut MITOVASC, UMR INSERM U1083 and CNRS 6015, Service de Cardiologie, CHU Angers, Université Angers, Angers, France.
Loïc BièreInstitut MITOVASC, UMR INSERM U1083 and CNRS 6015, Service de Cardiologie, CHU Angers, Université Angers, Angers, France.
Fabrice PrunierInstitut MITOVASC, UMR INSERM U1083 and CNRS 6015, Service de Cardiologie, CHU Angers, Université Angers, Angers, France. faprunier@chu-angers.fr.
Centre National de la Recherche Scientifique · FRUniversité de Tours · FRCentre Hospitalier Annecy Genevois · FRHôpitaux Universitaires de Strasbourg · FRLaval Mayenne Technopole · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of remote ischemic preconditioning (RIPC) to prevent contrast-induced nephropathy (CIN) following percutaneous coronary angiography in at-risk patients is controversial. No evidence exists regarding potential RIPC positive effects on renal function and clinical outcomes in the long-term. The PREPARE study was a randomized, prospective, multicenter, and double-blinded trial. A total of 222 patients scheduled for coronary angiography and/or percutaneous transluminal coronary angioplasty with an estimated glomerular filtration rate (eGFR) < 40 mL/min/1.73 m

Indexed as

Acute Kidney InjuryAgedAged, 80 and overCoronary AngiographyFemaleHumansIncidenceIschemic PreconditioningKidney Function TestsMaleMiddle AgedPercutaneous Coronary InterventionRisk AssessmentRisk Factors

Identifiers

PMID31427688
PMCPMC6700075
OpenAlexW2969771950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.